Lee Horobin - TBG Diagnostics Insider

TBG Diagnostics Limited -- Australia Stock  

 0.16  0.00  0.00%

General Manager of Fin.

Mr. Lee Horobin serves as General Manager Finance of Progen Pharmaceuticals Limited since August 23 2012. He served as Company Secretary from March 1 2010 to May 24 2010 and Acting General Manager Finance from March 1 2010 to May 2010. He has commenced with Progen on an interim basis due to an extended period of absence of Mr. Paul Dixon
  Executive Since 2012  CPA    
61 7 3273 9133  http://www.tbgbio.com
Horobin is a member of CPA Australia and has held company secretarial positions in previous roles.

Management Efficiency

The company has return on total asset (ROA) of (47.62) % which means that it has lost $47.62 on every $100 spent on asset. This is way below average.

Similar Executives

Showing few of many executives

EXECUTIVE Since

Melanie WilliamsSouth32 Limited
2016
Robert WatsonFortescue Metals Group Limited
N/A
Alison TerryFortescue Metals Group Limited
2017
Michael NossalNewcrest Mining Limited
2015
Alex VolanteSouth32 Limited
N/A
Nicole DuncanSouth32 Limited
N/A
David PitofskyNews Corporation
2015
Simon ShakesheffStockland Corporation Limited
2013
PAUL HARVEYSouth32 Limited
2015
Sue WilsonSouth32 Limited
2015
John OGradyRamsay Health Care Limited
2007
Mark ThomasFortescue Metals Group Limited
2014
Stuart GaleFortescue Metals Group Limited
2014
Chris MaitlandNewcrest Mining Limited
2015
Claire HannonNewcrest Mining Limited
2016
Phil StephensonNewcrest Mining Limited
2015
Craig JonesNewcrest Mining Limited
2015
Dale CalhounSouth32 Limited
2015
Jane ThomasNewcrest Mining Limited
2016
Geoffrey DayNewcrest Mining Limited
2014
Francesca LeeNewcrest Mining Limited
2015

Entity Summary

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. TBG Diagnostics Limited (PGL) is traded on Australian Securities Exchange in Australia. It is located in Darra, QLD and employs 10 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add TBG Diagnostics Limited to your portfolio

Top Management

TBG Diagnostics Limited Leadership Team
Keith Dredge, Director, Ph.D
YuZen Cheng, Director
Lee Horobin, Executive, CPA
Generosa Hipona, Executive
Blair Lucas, Executive
Hongjen Chang, Director
Fleur Lankesheer, Director
Leslie Tillack, CEO
ChiaChuan Chang, Director
ShiChung Chang, Director, Ph.D
Indrajit Arulampalam, Chairman
Emily Lee, Director
Christopher Harvey, Director

Stock Performance

TBG Diagnostics Performance Indicators